Allworth Financial’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46K Buy
3,592
+1,858
+107% +$23.7K ﹤0.01% 2382
2025
Q4
$15.6K Buy
1,734
+750
+76% +$10.3K ﹤0.01% 2970
2025
Q3
$17K Buy
984
+12
+1% +$148 ﹤0.01% 2806
2025
Q2
$9.12K Buy
972
+390
+67% +$3.2K ﹤0.01% 2941
2025
Q1
$4.76K Buy
582
+426
+273% +$4.3K ﹤0.01% 2785
2024
Q4
$1.72K Buy
156
+94
+152% +$1.47K ﹤0.01% 3206
2024
Q3
$1.27K Sell
62
-76
-55% -$1.75K ﹤0.01% 3137
2024
Q2
$3.46K Sell
138
-694
-83% -$16.5K ﹤0.01% 2682
2024
Q1
$22.9K Buy
832
+139
+20% +$3.86K ﹤0.01% 1696
2023
Q4
$21.1K Buy
693
+670
+2,913% +$19.3K ﹤0.01% 1623
2023
Q3
$728 Buy
23
+4
+21% +$155 ﹤0.01% 2943
2023
Q2
$775 Sell
19
-5
-21% -$203 ﹤0.01% 2806
2023
Q1
$895 Buy
+24
New +$941 ﹤0.01% 2707
2022
Q4
Sell
-33
Closed -$2K 3136
2022
Q3
$2K Buy
33
+21
+175% +$1.3K ﹤0.01% 2187
2022
Q2
$1K Buy
+12
New +$609 ﹤0.01% 2207

Other funds holding NTLA